Merck Showcases New Innovations at Analytica 2016May 10, 2016
– Life science expertise and innovations for simplified, dynamic and precise live cell analysis
DARMSTADT, Germany, May 10, 2016 /PRNewswire/ — Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.
Innovations that enable faster, easier and more reliable research, including the CellASIC™ ONIX 2 Microfluidic Platform, a tool for live cell analysis are among Merck’s products on display at booth #A1408.
“Merck’s new products exemplify our commitment to developing solutions that solve difficult challenges for our customers,” said Udit Batra, Member of the Merck Executive Board and CEO, Life Science. “Merck has a proven track record in life science and continues to innovate with our new CellASIC™ Platform.”
The CellASIC™ Platform allows researchers to monitor responses to perfusion, temperature and gas environment changes in live cells and track individual cell responses over time for truly dynamic cellular analysis. It also offers constant, stable imaging conditions while maintaining the health of cells, and combines the highest precision controls, superior functionality and simplest user interface for a unique live cell analysis experience.
Merck will also showcase the following innovations at the show:
- Amicon® Stirred Cells – New ultrafiltration devices compatible with large-volume samples and offer easier set-up, more secure assembly, better device integrity and compatibility with more membranes.
- Samplicity® G2 Filtration System – A new technology that provides a convenient, high throughput alternative to syringe-tip filters for chromatography sample prep.
- Spectroquant® Prove Spectrophotometers – New class of spectrophotometers which allow simplified, durable and secure analysis of waste water, drinking water, beverages and process water.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of €12.85 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.